Molecular Mechanisms and Clinical Manifestations of Catecholamine Dysfunction in the Eye in Parkinson's Disease As a Basis for Developing Early Diagnosis.

Pavlenko, T A; Chesnokova, N B; Nodel, M R; Kim, A R; Ugrumov, M V

Pavlenko, T A; Chesnokova, N B; Nodel, M R; Kim, A R; Ugrumov, M V.

Afiliação

Pavlenko TA; Helmholtz Moscow Research Institute of Eye Diseases of Ministry of Health of the Russian Federation, Moscow, 105062 Russia.
Chesnokova NB; Helmholtz Moscow Research Institute of Eye Diseases of Ministry of Health of the Russian Federation, Moscow, 105062 Russia.
Nodel MR; Sechenov First Moscow State Medical University, Moscow, 119991 Russia.
Kim AR; Pirogov Russian National Research Medical University, Russian Clinical and Research Center of Gerontology, Moscow, 129226 Russia.
Ugrumov MV; Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, 119334 Russia.

Acta Naturae ; 12(2): 52-62, 2020.

Article em En | MEDLINE | ID: mdl-32742727

Palavras-chave

Parkinson's disease; biomarkers; dopamine; intraocular pressure; lacrimal fluid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google